Technische Universität München
Stories about Medical diagnosis
- more
Technische Universität München
Fighting corona with machine learning
moreTauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia
moreTechnische Universität München
A new light source for the chip industry: light-emitting silicon-germanium alloys
moreBosch Healthcare Solutions GmbH
Bosch developing COVID-19-(SARS-CoV-2) rapid testing kit for the Vivalytic platform / Test delivers reliable results at the point of care in less than 2.5 hours
moreHitachi Medical Systems Europe Holding AG
Hitachi Medical Systems Europe launches "ARIETTA 750", the new model from the ARIETTA series of diagnostic ultrasound platforms / This model inherited premium class technologies
moreTechnische Universität München
Major project for Munich neurosciences
moreWirtschaftsförderung Sachsen GmbH
Saxony and Great Britain expand cooperation in state-of-the-art medical diagnostics / "Medical Innovation & Diagnostics" - start-ups bring research results into clinical practice rapidly
moreWirtschaftsförderung Sachsen GmbH
Saxony and Great Britain expand cooperation in state-of-the-art medical diagnostics
moreHitachi Medical Systems Europe Holding AG
Hitachi and Centre Léon Bérard cancer center in Lyon to launch a research collaboration in the fight against cancer with AI
moreUEG Week Exhibition Celebrates 50 Years of Colonoscopy in Preventing and Diagnosing Gastrointestinal Diseases, Including Colorectal Cancer
moreFace Up To Rosacea: Galderma Launches Online Support to Empower and Equip Rosacea Sufferers to Discuss the True Burden of Their Disease With a Dermatologist
moreKnowledge Is Power - Celebrating 10 Years of Sysmex Academy and More
moreKnowledge is power - celebrating 10 years of Sysmex Academy and more
moreSysmex Europe GmbH wins the Silver Award for 'Best Customer Training Program' in Excellence in Learning Awards
moreNewly Published ROSacea COnsensus (ROSCO) Expert Recommendations Encourage Dermatologists to Upweight Burden-related Discussions, Aim For 'Complete Clearance' of Symptoms and Consider Combination Therapy For Severe Patients
moreSysmex Inostics publishes first feasibility study of NGS-based liquid biopsy to complement early breast cancer screening by imaging
moreDebiopharm and BIOASTER join forces to expand research to combat infectious diseases
moreFraunhofer Institut für Angewandte Festkörperphysik IAF
Fingerprint spectroscopy within a millisecond
moreNew Study Shows Rifaximin Significantly Reduced the Number and Length of Hospitalisations in Patients With Overt Hepatic Encephalopathy (HE) Awaiting Liver Transplatation
moreSpecific identification of chronic lung disease in premature babies
moreGenePOC, a subsidiary of Debiopharm Group, reaches an agreement with Meridian Bioscience for the acquisition of their molecular diagnostics business
moreRNA Transport in Neurons - Staufen2 detects its target transcripts in a complex manner
more#RosaceaNoFilter: Online Influencers Take the Lead in Raising Rosacea Awareness in Galderma's Empowering Rosacea Awareness Month Social Media Campaign
moreSOPHiA GENETICS Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection
moreGenePOC obtains CE marked for its GenePOC(TM) Carba test
moreNorgine New Study Highlights Need to Increase Public Understanding of Important Role of Colonoscopy in Preventing and Diagnosing Gastrointestinal Diseases, Including Colorectal Cancer
moreTechnische Universität München
Black nanoparticles slow the growth of tumors
moreMundipharma EDO GmbH: US FDA Grants Orphan Drug Designation for Tinostamustine in Very Rare Blood Cancer
moreGenePOC obtains FDA clearance for its GenePOC(TM) Strep A test in the US
more
12Next